TBPMQTetra Bio-Pharma Inc.

About Tetra Bio-Pharma Inc. (TBPMQ)

Tetra Bio-Pharma Inc. (TBPMQ) is a Biotechnology company headquartered in Longueuil, QC, Canada whose shares trade over-the-counter on the Expert Market tier.

Tetra is a development stage biopharmaceutical company in immunomodulator drug discovery and development with a U.S. Food and Drug Administration ("FDA") and a Health Canada approved clinical program aimed at bringing novel prescription drugs and treatments to relieve symptoms associated with advanced cancer pain, chronic pain, Acute Respiratory Distress Syndrome ("ARDS"), sepsis and ophthalmic disease. Tetra's head office is located at 2316 St. Joseph Blvd., Orleans, Ontario, K1C 1E8.

Products and services

Drug research and drug development.

TBPMQ key facts

Ticker symbol

TBPMQ

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Longueuil, QC, Canada

Country of incorporation

CA

Employees

21

Estimated market cap

$51.6K (as of Nov 7, 2024)

Shares outstanding

515,634,104

Reporting standard

International Reporting: Toronto Stock Exchange

Audit status

Audited

Fiscal year end

11/30

Latest filing

Interim Financial Report (Aug 31, 2022)

Tetra Bio-Pharma Inc. leadership

• Leslie Auld — CFO

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with T